From Merck Press Release 01.09.09 Merck Receives Complete Response Letter from the FDA WHITEHOUSE STATION, N.J., Jan. 9, 2009 - Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has issued a second complete response letter regarding the … [Read more...] about Use of GARDASIL in Women Ages 27 through 45
Merck
2008 Was Not a Good Year for Merck
Gardasil HPV-Vaccine is Just One Of Merck's Troublesome Issues The forth quarter earning reports, the report card for publicly held companies, held no good news for Merck or its stockholders. Merck released its not overly optimistic guidance for 2009 that forecasted earnings and … [Read more...] about 2008 Was Not a Good Year for Merck
Merck Faces Another Tough Year
What happened to Merck chief Richard amazing turnaround? Has Merck's comeback turned into a wipeout? Under chief Richard Clark, an unassuming company lifer, Merck (nyse: MRK - news - people ) staged a seemingly amazing turnabout from the dark days of 2004, when … [Read more...] about Merck Faces Another Tough Year
Glaxo wins European contract for Cervarix
GlaxoSmithKline has won another European contract for the cervical cancer vaccine Cervarix. The Dutch government selected Cervarix for a new program to vaccinate all girls aged 12 with a catch-up program for girls aged 13 to 16 in the second half of 2009. In the first year some … [Read more...] about Glaxo wins European contract for Cervarix
Backlash Against Merck Mandatory Vaccine Ploy Continues
The Journal of Law, Medicine & Ethics weighs in on mandatory Gardasil shots A trio of academics have joined the 'Pro/Con' debate over the policy of requiring girls to be vaccinated with Merck’s Gardasil. In a recent issue of the Journal of Law, Medicine & Ethics, Gail … [Read more...] about Backlash Against Merck Mandatory Vaccine Ploy Continues